In this video, Dr. Brian G.M. Durie explains how high-dose melphalan therapy that precedes an ASCT may cause some side effects and how an ASCT itself may result in some low-risk complications.
The BOTTOM LINE: Autologous stem cell transplant is still a recommended therapy, if feasible, and it is mostly manageable.
Please subscribe to our channel!
Subscribe to International Myeloma Foundation: [ Ссылка ]
Visit our website at: [ Ссылка ]
Find us online:
Facebook: [ Ссылка ]
Google+: [ Ссылка ]
IMF on twitter: @IMFMyeloma ([ Ссылка ])
Dr. Durie on twitter: @BrianDurieMD ([ Ссылка ])
Support the IMF! [ Ссылка ]
Category
Nonprofits & Activism
License
Standard YouTube License
